Skip to main content

Table 2 Hepatitis B serum markers

From: Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed Western Region in China---case report and review of the literature

 

HBsAg(COI)

anti- HBs(IU/L)

HBeAg(COI)

HBeAb(COI)

HBcAb(COI)

2012–11

28.1

< 2

0.1

0.011

0.009

2013–11

11.11

< 2

0.076

0.008

0.005

2016–06

5.11

< 2

0.03

0.043

0.003

2017–12

2.36

< 2

0.111

0.084

0.010

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us